{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:33:42Z","timestamp":1789832022511,"version":"4.0.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["19H03700"],"award-info":[{"award-number":["19H03700"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["17K09990"],"award-info":[{"award-number":["17K09990"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>We hypothesized that Beh\u00e7et\u2019s disease (BD) consists of several clinical subtypes with different severity, resulting in heterogeneity of the disease. Here, we conducted a study to identify clinical clusters of BD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 657 patients registered in the Yokohama City University (YCU) regional BD registry between 1990 and 2018, as well as 6754 patients who were initially registered in the Japanese Ministry of Health, Labour and Welfare (MHLW) database between 2003 and 2014, were investigated. The YCU registry data regarding the clinical manifestations of BD, human leukocyte antigen (HLA) status, treatments, and hospitalizations were analyzed first, followed by similar analyses of the MHLW for validation. A hierarchical cluster analysis was independently performed in both patient groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A hierarchical cluster analysis determined five independent clinical clusters in the YCU cohort. Individual counterparts of the YCU clusters were confirmed in the MHLW registry. Recent phenotypical evolutions of BD in Japan, such as increased gastrointestinal (GI) involvement, reduced complete type according to the Japan Criteria, and reduced HLA-B51 positivity were associated with chronologically changing proportions of the clinical clusters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this study, we identified independent clinical clusters among BD patients in Japan and found that the proportion of each cluster varied over time. We propose five independent clusters namely \u201cmucocutaneous\u201d, \u201cmucocutaneous with arthritis\u201d, \u201cneuro\u201d, \u201cGI\u201d, and \u201ceye.\u201d<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-020-02406-6","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T08:04:02Z","timestamp":1612166642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Beh\u00e7et\u2019s disease in Japan"],"prefix":"10.1186","volume":"23","author":[{"given":"Yutaro","family":"Soejima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9488-661X","authenticated-orcid":false,"given":"Yohei","family":"Kirino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Takeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Kurosawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusuke","family":"Yoshimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Asami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Nagaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Ishigatsubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhisa","family":"Mizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,1]]},"reference":[{"issue":"17","key":"2406_CR1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1056\/NEJM199910213411707","volume":"341","author":"T Sakane","year":"1999","unstructured":"Sakane T, Takeno M, Suzuki N, Inaba G. Behcet\u2019s disease. N Engl J Med. 1999;341(17):1284\u201391.","journal-title":"N Engl J Med"},{"issue":"2","key":"2406_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","volume":"14","author":"H Yazici","year":"2018","unstructured":"Yazici H, Seyahi E, Hatemi G, Yazici Y. Behcet syndrome: a contemporary view. Nat Rev Rheumatol. 2018;14(2):107\u201319.","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"2406_CR3","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/art.24642","volume":"61","author":"M de Menthon","year":"2009","unstructured":"de Menthon M, Lavalley MP, Maldini C, Guillevin L, Mahr A. HLA-B51\/B5 and the risk of Behcet\u2019s disease: a systematic review and meta-analysis of case-control genetic association studies. Arthritis Rheum. 2009;61(10):1287\u201396.","journal-title":"Arthritis Rheum"},{"issue":"7842","key":"2406_CR4","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/S0140-6736(73)93343-6","volume":"2","author":"S Ono","year":"1973","unstructured":"Ono S, Aoki K, Sugiura S, Nakayama E, Itakura K. Letter: HL-A5 and Behcet\u2019s disease. Lancet. 1973;2(7842):1383\u20134.","journal-title":"Lancet"},{"issue":"24","key":"2406_CR5","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.1073\/pnas.1406575111","volume":"111","author":"MJ Ombrello","year":"2014","unstructured":"Ombrello MJ, Kirino Y, de Bakker PI, Gul A, Kastner DL, Remmers EF. Behcet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity. Proc Natl Acad Sci U S A. 2014;111(24):8867\u201372.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2406_CR6","first-page":"808","volume":"77","author":"G Hatemi","year":"2018","unstructured":"Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kotter I, Leccese P, et al. 2018 update of the EULAR recommendations for the management of Behcet\u2019s syndrome. Ann Rheum Dis. 2018;77(6):808\u201318.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"2406_CR7","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1080\/14712598.2017.1328496","volume":"17","author":"AC Desbois","year":"2017","unstructured":"Desbois AC, Vallet H, Domont F, Comarmond C, Cacoub P, Saadoun D. Management of severe complications in Behcet\u2019s disease with TNF inhibitors. Expert Opin Biol Ther. 2017;17(7):853\u20139.","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"2406_CR8","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/ard.43.6.783","volume":"43","author":"H Yazici","year":"1984","unstructured":"Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdogan H, Serdaroglu S, Ersanli M, Ulku BY, Muftuoglu AU. Influence of age of onset and patient\u2019s sex on the prevalence and severity of manifestations of Behcet\u2019s syndrome. Ann Rheum Dis. 1984;43(6):783\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"2406_CR9","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1093\/rheumatology\/kex285","volume":"56","author":"T Ishido","year":"2017","unstructured":"Ishido T, Horita N, Takeuchi M, Kawagoe T, Shibuya E, Yamane T, Hayashi T, Meguro A, Ishido M, Minegishi K, et al. Clinical manifestations of Behcet\u2019s disease depending on sex and age: results from Japanese nationwide registration. Rheumatology (Oxford). 2017;56(11):1918\u201327.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"2406_CR10","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/annrheumdis-2015-208491","volume":"75","author":"I Kone-Paut","year":"2016","unstructured":"Kone-Paut I, Shahram F, Darce-Bello M, Cantarini L, Cimaz R, Gattorno M, Anton J, Hofer M, Chkirate B, Bouayed K, et al. Consensus classification criteria for paediatric Behcet\u2019s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2016;75(6):958\u201364.","journal-title":"Ann Rheum Dis"},{"key":"2406_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-4-431-54487-6","volume-title":"Beh\u00e7et\u2019s disease: from genetics to therapies","author":"Y Ishigatsubo","year":"2015","unstructured":"Ishigatsubo Y, Takeno M. Overview. In: Ishigatsubo Y, editor. Beh\u00e7et\u2019s disease: from genetics to therapies. Tokyo: Springer Japan; 2015. p. 1\u201320."},{"issue":"6","key":"2406_CR12","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00296-013-2838-5","volume":"34","author":"H Ideguchi","year":"2014","unstructured":"Ideguchi H, Suda A, Takeno M, Miyagi R, Ueda A, Ohno S, Ishigatsubo Y. Gastrointestinal manifestations of Behcet\u2019s disease in Japan: a study of 43 patients. Rheumatol Int. 2014;34(6):851\u20136.","journal-title":"Rheumatol Int"},{"issue":"1","key":"2406_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1115-x","volume":"18","author":"Y Kirino","year":"2016","unstructured":"Kirino Y, Ideguchi H, Takeno M, Suda A, Higashitani K, Kunishita Y, Takase-Minegishi K, Tamura M, Watanabe T, Asami Y, et al. Continuous evolution of clinical phenotype in 578 Japanese patients with Behcet\u2019s disease: a retrospective observational study. Arthritis Res Ther. 2016;18(1):217.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"2406_CR14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/bjd.12661","volume":"170","author":"DY Kim","year":"2014","unstructured":"Kim DY, Choi MJ, Cho S, Kim DW, Bang D. Changing clinical expression of Behcet disease in Korea during three decades (1983\u20132012): chronological analysis of 3674 hospital-based patients. Br J Dermatol. 2014;170(2):458\u201361.","journal-title":"Br J Dermatol"},{"issue":"8","key":"2406_CR15","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1365-4632.2006.02832.x","volume":"45","author":"R Sarica-Kucukoglu","year":"2006","unstructured":"Sarica-Kucukoglu R, Akdag-Kose A, Kayabal IM, Yazganoglu KD, Disci R, Erzengin D, Azizlerli G. Vascular involvement in Behcet\u2019s disease: a retrospective analysis of 2319 cases. Int J Dermatol. 2006;45(8):919\u201321.","journal-title":"Int J Dermatol"},{"issue":"6","key":"2406_CR16","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/14397595.2018.1558752","volume":"29","author":"F Davatchi","year":"2019","unstructured":"Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Abdolahi BS, Nadji A, Faezi T, Akhlaghi M, Ghodsi Z, Karimi N, et al. Behcet\u2019s disease in Iran: analysis of 7641 cases. Mod Rheumatol. 2019;29(6):1023\u201330.","journal-title":"Mod Rheumatol"},{"key":"2406_CR17","doi-asserted-by":"crossref","unstructured":"Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y. Behcet disease: evolution of clinical manifestations. Medicine (Baltimore). 2011;90(2):125\u20133.","DOI":"10.1097\/MD.0b013e318211bf28"},{"issue":"4","key":"2406_CR18","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1080\/14397595.2019.1649103","volume":"30","author":"Y Mizuki","year":"2020","unstructured":"Mizuki Y, Horita N, Horie Y, Takeuchi M, Ishido T, Mizuki R, Kawagoe T, Shibuya E, Yuda K, Ishido M, et al. The influence of HLA-B51 on clinical manifestations among Japanese patients with Behcet\u2019s disease: a nationwide survey. Mod Rheumatol. 2020;30(4):708\u201314.","journal-title":"Mod Rheumatol"},{"issue":"2","key":"2406_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00535-016-1209-x","volume":"52","author":"E Kuwahara","year":"2017","unstructured":"Kuwahara E, Murakami Y, Nakamura T, Inoue N, Nagahori M, Matsui T, Watanabe M, Suzuki Y, Nishiwaki Y. Factors associated with exacerbation of newly diagnosed mild ulcerative colitis based on a nationwide registry in Japan. J Gastroenterol. 2017;52(2):185\u201393.","journal-title":"J Gastroenterol"},{"issue":"2","key":"2406_CR20","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5217\/ir.2016.14.2.111","volume":"14","author":"WK Ng","year":"2016","unstructured":"Ng WK, Wong SH, Ng SC. Changing epidemiological trends of inflammatory bowel disease in Asia. Intest Res. 2016;14(2):111\u20139.","journal-title":"Intest Res"},{"issue":"5","key":"2406_CR21","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/rheumatology\/ker428","volume":"51","author":"C Maldini","year":"2012","unstructured":"Maldini C, Lavalley MP, Cheminant M, de Menthon M, Mahr A. Relationships of HLA-B51 or B5 genotype with Behcet\u2019s disease clinical characteristics: systematic review and meta-analyses of observational studies. Rheumatology (Oxford). 2012;51(5):887\u2013900.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"2406_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/14397595.2018.1457424","volume":"29","author":"A Suwa","year":"2019","unstructured":"Suwa A, Horita N, Ishido T, Takeuchi M, Kawagoe T, Shibuya E, Yamane T, Hayashi T, Meguro A, Ishido M, et al. The ocular involvement did not accompany with the genital ulcer or the gastrointestinal symptoms at the early stage of Behcet\u2019s disease. Mod Rheumatol. 2019;29(2):357\u201362.","journal-title":"Mod Rheumatol"},{"issue":"8","key":"2406_CR23","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1002\/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6","volume":"43","author":"EJ Kroot","year":"2000","unstructured":"Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van't Hof M, van de Putte LB, van Rijswijk MH, van Venrooij WJ, van Riel PL. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000;43(8):1831\u20135.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"2406_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/art.24135","volume":"60","author":"B Ding","year":"2009","unstructured":"Ding B, Padyukov L, Lundstrom E, Seielstad M, Plenge RM, Oksenberg JR, Gregersen PK, Alfredsson L, Klareskog L. Different patterns of associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum. 2009;60(1):30\u20138.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"2406_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/BOR.0b013e328336ba63","volume":"22","author":"J Holoshitz","year":"2010","unstructured":"Holoshitz J. The rheumatoid arthritis HLA-DRB1 shared epitope. Curr Opin Rheumatol. 2010;22(3):293\u20138.","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"2406_CR26","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/art.23450","volume":"58","author":"G Hatemi","year":"2008","unstructured":"Hatemi G, Fresko I, Tascilar K, Yazici H. Increased enthesopathy among Behcet\u2019s syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum. 2008;58(5):1539\u201345.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2406_CR27","first-page":"99","volume":"17","author":"CT Jun Hayashi","year":"2005","unstructured":"Jun Hayashi CT, Sugano Y, Nonaka N, Enomoto M, Ishii O, Nakamura T, Matsuda T, Sugimmori H. Study on clinical manifestations of Behcet\u2019s disease by cluster analysis. Clin Rheumatol Relat Res. 2005;17(2):99\u2013105.","journal-title":"Clin Rheumatol Relat Res"},{"issue":"3","key":"2406_CR28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12016-012-8319-x","volume":"43","author":"H Yazici","year":"2012","unstructured":"Yazici H, Ugurlu S, Seyahi E. Behcet syndrome: is it one condition? Clin Rev Allergy Immunol. 2012;43(3):275\u201380.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"2406_CR29","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s11739-019-02046-y","volume":"14","author":"E Seyahi","year":"2019","unstructured":"Seyahi E. Phenotypes in Behcet\u2019s syndrome. Intern Emerg Med. 2019;14(5):677\u201389.","journal-title":"Intern Emerg Med"},{"issue":"6","key":"2406_CR30","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/rheumatology\/ker423","volume":"51","author":"M Karaca","year":"2012","unstructured":"Karaca M, Hatemi G, Sut N, Yazici H. The papulopustular lesion\/arthritis cluster of Behcet\u2019s syndrome also clusters in families. Rheumatology (Oxford). 2012;51(6):1053\u201360.","journal-title":"Rheumatology (Oxford)"},{"key":"2406_CR31","first-page":"8","volume-title":"Guide for the diagnosis of Beh\u00e7et\u2019s disease. Report of Beh\u00e7et\u2019s Disease Research Committee, Japan","author":"Y Mizushima","year":"1987","unstructured":"Mizushima Y, Inaba G, Mimura Y. Guide for the diagnosis of Beh\u00e7et\u2019s disease. Report of Beh\u00e7et\u2019s Disease Research Committee, Japan; 1987. p. 8\u201317."},{"issue":"8697","key":"2406_CR32","first-page":"1078","volume":"335","author":"Criteria for diagnosis of Behcet\u2019s disease","year":"1990","unstructured":"Criteria for diagnosis of Behcet\u2019s disease. International study group for Behcet\u2019s disease. Lancet. 1990;335(8697):1078\u201380.","journal-title":"Lancet"},{"issue":"3","key":"2406_CR33","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"The International Criteria for Behcet's Disease","year":"2014","unstructured":"The International Criteria for Behcet's Disease. (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338\u201347.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2406_CR34","unstructured":"Calin\u0301ski T, J Harabasz J. A dendrite method for cluster analysis. Communications in Statistics. 1974;3(1):1\u201327."},{"key":"2406_CR35","unstructured":"Hartigan JA. Clustering analysis. Wiley; 1975."},{"issue":"1","key":"2406_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2307\/2531893","volume":"44","author":"WJ Krzanowski","year":"1985","unstructured":"Krzanowski WJ, Lai YT. A criterion for determining the number of clusters in a data set. Biometrics. 1985;44(1):23\u201334.","journal-title":"Biometrics."},{"issue":"4","key":"2406_CR37","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/art.1780400425","volume":"40","author":"V Hamuryudan","year":"1997","unstructured":"Hamuryudan V, Ozyazgan Y, Hizli N, Mat C, Yurdakul S, Tuzun Y, Senocak M, Yazici H. Azathioprine in Behcet\u2019s syndrome: effects on long-term prognosis. Arthritis Rheum. 1997;40(4):769\u201374.","journal-title":"Arthritis Rheum."},{"issue":"2","key":"2406_CR38","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1080\/09273948.2018.1559928","volume":"28","author":"H Nakahara","year":"2020","unstructured":"Nakahara H, Kaburaki T, Tanaka R, Yoshida A, Takamoto M, Kawata M, Fujino Y, Kawashima H, Aihara M. Comparisons of clinical features in Japanese patients with Behce\u2019s uveitis treated in the 1990s and the 2000s. Ocul Immunol Inflamm. 2020;28(2):262\u20139.","journal-title":"Ocul Immunol Inflamm."},{"issue":"1","key":"2406_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/s10165-006-0541-z","volume":"17","author":"K Aramaki","year":"2007","unstructured":"Aramaki K, Kikuchi H, Hirohata S. HLA-B51 and cigarette smoking as risk factors for chronic progressive neurological manifestations in Behcet\u2019s disease. Mod Rheumatol. 2007;17(1):81\u20132.","journal-title":"Mod Rheumatol."},{"issue":"4","key":"2406_CR40","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/14397595.2018.1493065","volume":"29","author":"A Malek Mahdavi","year":"2019","unstructured":"Malek Mahdavi A, Khabbazi A, Yaaghoobian B, Ghojazadeh M, Agamohammadi R, Kheyrollahiyan A, Rashtchizadeh N. Cigarette smoking and risk of Behcet\u2019s disease: a propensity score matching analysis. Mod Rheumatol. 2019;29(4):633\u20139.","journal-title":"Mod Rheumatol."},{"issue":"11","key":"2406_CR41","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1111\/jdv.15708","volume":"33","author":"YB Lee","year":"2019","unstructured":"Lee YB, Lee JH, Lee SY, Yu DS, Han KD, Park YG. Association between smoking and Behcet\u2019s disease: a nationwide population-based study in Korea. J Eur Acad Dermatol Venereol. 2019;33(11):2114\u201322.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"5 Suppl 24","key":"2406_CR42","first-page":"S77","volume":"19","author":"SW Rizvi","year":"2001","unstructured":"Rizvi SW, McGrath H Jr. The therapeutic effect of cigarette smoking on oral\/genital aphthosis and other manifestations of Behcet\u2019s disease. Clin Exp Rheumatol. 2001;19(5 Suppl 24):S77\u20138.","journal-title":"Clin Exp Rheumatol."},{"issue":"4 Suppl 60","key":"2406_CR43","first-page":"S86","volume":"28","author":"H Direskeneli","year":"2010","unstructured":"Direskeneli H, Mumcu G. A possible decline in the incidence and severity of Behcet\u2019s disease: implications for an infectious etiology and oral health. Clin Exp Rheumatol. 2010;28(4 Suppl 60):S86\u201390.","journal-title":"Clin Exp Rheumatol."},{"issue":"4","key":"2406_CR44","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.autrev.2014.11.009","volume":"14","author":"C Consolandi","year":"2015","unstructured":"Consolandi C, Turroni S, Emmi G, Severgnini M, Fiori J, Peano C, Biagi E, Grassi A, Rampelli S, Silvestri E, et al. Behcet\u2019s syndrome patients exhibit specific microbiome signature. Autoimmun Rev. 2015;14(4):269\u201376.","journal-title":"Autoimmun Rev."},{"issue":"8","key":"2406_CR45","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3899\/jrheum.180412","volume":"46","author":"M Kishimoto","year":"2019","unstructured":"Kishimoto M, Yoshida K, Ichikawa N, Inoue H, Kaneko Y, Kawasaki T, Matsui K, Morita M, Suda M, Tada K, et al. Clinical characteristics of patients with spondyloarthritis in Japan in comparison with other regions of the world. J Rheumatol. 2019;46(8):896\u2013903.","journal-title":"J Rheumatol."},{"issue":"8","key":"2406_CR46","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/ng.625","volume":"42","author":"EF Remmers","year":"2010","unstructured":"Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet\u2019s disease. Nat Genet. 2010;42(8):698\u2013702.","journal-title":"Nat Genet."},{"issue":"2","key":"2406_CR47","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ng.2520","volume":"45","author":"Y Kirino","year":"2013","unstructured":"Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, Ozyazgan Y, Sacli FS, Erer B, Inoko H, et al. Genome-wide association analysis identifies new susceptibility loci for Behcet\u2019s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet. 2013;45(2):202\u20137.","journal-title":"Nat Genet."},{"key":"2406_CR48","doi-asserted-by":"crossref","unstructured":"Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, Ito N, Kera J, Okada E, Yatsu K, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet\u2019s disease susceptibility loci. Nat Genet. 2010;42(8):703\u20136.","DOI":"10.1038\/ng.624"},{"issue":"4 Suppl 67","key":"2406_CR49","first-page":"S3","volume":"29","author":"A Gul","year":"2011","unstructured":"Gul A. Genome-wide association studies in Behcet\u2019s disease: expectations and promises. Clin Exp Rheumatol. 2011;29(4 Suppl 67):S3\u20135.","journal-title":"Clin Exp Rheumatol."},{"key":"2406_CR50","doi-asserted-by":"publisher","first-page":"39850","DOI":"10.1038\/srep39850","volume":"7","author":"SW Kim","year":"2017","unstructured":"Kim SW, Jung YS, Ahn JB, Shin ES, Jang HW, Lee HJ, Il Kim T, Kim DY, Bang D, Kim WH, et al. Identification of genetic susceptibility loci for intestinal Behcet\u2019s disease. Sci Rep. 2017;7:39850.","journal-title":"Sci Rep."},{"issue":"9","key":"2406_CR51","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.2169\/internalmedicine.2035-18","volume":"58","author":"Y Kirino","year":"2019","unstructured":"Kirino Y, Nakajima H. Clinical and genetic aspects of Behcet\u2019s disease in Japan. Intern Med. 2019;58(9):1199\u2013207.","journal-title":"Intern Med."},{"issue":"1","key":"2406_CR52","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s13075-019-1928-5","volume":"21","author":"N Tsuchida","year":"2019","unstructured":"Tsuchida N, Kirino Y, Soejima Y, Onodera M, Arai K, Tamura E, Ishikawa T, Kawai T, Uchiyama T, Nomura S, et al. Haploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behcet\u2019s disease. Arthritis Res Ther. 2019;21(1):137.","journal-title":"Arthritis Res Ther."},{"key":"2406_CR53","unstructured":"Arida A, Vaiopoulos G, Markomichelakis N, Kaklamanis P, Sfikakis PP. Are clusters of patients with distinct clinical expression present in Behcet\u2019s disease? Clin Exp Rheumatol. 2009;27(2 Suppl 53):S48\u201351."},{"issue":"5","key":"2406_CR54","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1056\/NEJM199002013220501","volume":"322","author":"H Yazici","year":"1990","unstructured":"Yazici H, Pazarli H, Barnes CG, Tuzun Y, Ozyazgan Y, Silman A, Serdaroglu S, Oguz V, Yurdakul S, Lovatt GE, et al. A controlled trial of azathioprine in Behcet\u2019s syndrome. N Engl J Med. 1990;322(5):281\u20135.","journal-title":"N Engl J Med."},{"key":"2406_CR55","doi-asserted-by":"crossref","unstructured":"Krause I, Rosen Y, Kaplan I, Milo G, Guedj D, Molad Y, Weinberger A. Recurrent aphthous stomatitis in Beh\u00e7et\u2019s disease: clinical features and correlation with systemic disease expression and severity. J Oral Pathol Med. 1999;28(5):193\u20136.","DOI":"10.1111\/j.1600-0714.1999.tb02023.x"},{"key":"2406_CR56","unstructured":"Krause I, Mader R, Sulkes J, Paul M, Uziel Y, Adawi M, Weinberger A. Beh\u00e7et\u2019s disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol. 2001;28(5):1033\u20136."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02406-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-020-02406-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02406-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T18:22:10Z","timestamp":1697739730000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02406-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2406"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02406-6","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]},"assertion":[{"value":"10 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of YCU (A191100002). This survey is based on the application of the opt-out strategy in accordance with Japan MHLW Epidemiological Research Ethics Guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Y. Kirino: Amgen (speaking and consultation fees); M. Takeno: Amgen (advisor for the clinical trial of Apremilast); and S. Nagaoka: Chugai, Bristol-Myers Squibb, Gilead (consultation fees).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"49"}}